Form 8-K - Current report:
SEC Accession No. 0001437749-17-019213
Filing Date
2017-11-14
Accepted
2017-11-14 08:32:17
Documents
3
Period of Report
2017-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K snbp20171113_8k.htm 8-K 25307
2 EXHIBIT 99.1 ex_100443.htm EX-99.1 206346
3 ex_100443img001.gif GRAPHIC 6888
  Complete submission text file 0001437749-17-019213.txt   242546
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Sun BioPharma, Inc. (Filer) CIK: 0001029125 (see all company filings)

EIN.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55242 | Film No.: 171198503
SIC: 2834 Pharmaceutical Preparations